Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Efficacy and Safety of Immunosuppression, Caplacizumab and Plasma Infusion Without Therapeutic Plasma Exchange in Immune-mediated Thrombotic Thrombocytopenic PurpuraCytopenia, Hemic and Lymphatic Diseases, blood platelet disease, hematologic disorder, thrombocytopenia, thrombotic microangiopathyRecruitingNot applicable2026-02-17NCT06291025

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
University Hospital, Rouen141

30 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Ap-Hm La ConceptionMarseilleFrance1
Ap-Hp Pitie SalpetriereParisFrance1
Ap-Hp Saint LouisParisFrance2
Ap-Hp St AntoineParisFrance1
CH PAUPauFrance1
CH Saint-NazaireSaint-NazaireFrance2
CH ValenciennesValenciennesFrance3
Chru BesanonBesançonFrance1
CHU AmiensAmiensFrance47
CHU AngersAngersFrance48
Chu BobignyBobignyFrance1
CHU BordeauxBordeauxFrance12
CHU Clermont-FerrandClermont-FerrandFrance19
Chu Edouard HerriotLyonFrance1
CHU LilleLilleFrance15
Chu LimogesLimogesFrance24
CHU MartiniqueFort-de-FranceMartinique4
CHU MontpellierMontpellierFrance23
Chu NancyNancyFrance1
Chu NantesNantesFrance45
CHU NiceNiceFrance4
CHU NimesNîmesFrance12
CHU ReimsReimsFrance35
Chu Reunion SudSaint-PierreReunion1
Chu RouenRouenFrance28